European Patent on Ascend Advanced Therapies' EpyQ® AAV Plasmid Technology Successfully Defended at the EPO

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

ASCEND-EU-Patent

More Like This

PR Newswire associated0

Ascend Unveils Proprietary Enhancers That Significantly Improve AAV Yields Without Compromising Quality

PR Newswire associated0

Ascend Completes GMP Certification for Quality Control Testing in Munich Facility

PR Newswire associated0

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

PR Newswire associated0

Ascend returns to Plastimagen with innovative new materials for Latin America

PR Newswire associated0

Biopharma Leaders Shape the Future of Drug Development at Veeva R&D and Quality Summit Europe

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia